Matches in SemOpenAlex for { <https://semopenalex.org/work/W2433159715> ?p ?o ?g. }
- W2433159715 endingPage "12" @default.
- W2433159715 startingPage "5" @default.
- W2433159715 abstract "Hepatic fibrosis is a common result of different chronic liver diseases caused by viral infections, alcohol abuse, nonalcoholic fatty liver disease (NAFLD), autoimmune disease and metabolic/genetic disorders. Hepatic fibrosis is a dynamic process which can, in some cases, be reversible with effective treatment (1, 2). Otherwise, it can progress to more advanced stages including cirrhosis where liver function is impaired and severe complications can occur such as variceal bleeding, ascites, portal hypertension, hepatocellular carcinoma and death (3). In 2009, chronic liver disease and cirrhosis were responsible for 143,000 hospitalizations, 11,000 in-hospital deaths (7.7% death rate), and 6.7 billion dollars of hospital charges in total (4).Accurately detecting and staging fibrosis is important in the management of chronic liver disease for initiating treatment and monitoring its effects on the liver. Chronic viral hepatitis C (HCV) infection is a significant cause of hepatic disease and its treatment may depend on the presence of substantial fibrosis (5, 6).It is well known that liver biopsy is the current reference method for the detection and staging of fibrosis. However, it is an invasive method and can cause undesired complications including bleeding (1.7%) (7) and death (0.01-1%) (7-9). The accuracy of liver biopsy is affected by sampling errors (20-33% of patients can have fibrosis stage misclassified by 1 category) (10, 11), and intra- and inter-operator inconsistency (Kappa coefficient 0.62 – 0.89, where 1 means perfect agreement) (11, 12). Furthermore, this approach is not well accepted by patients and physicians alike (13).Conventional noninvasive imaging techniques (ultrasound, computed-tomography, MRI) can visualize the morphologic changes of liver due to fibrosis and cirrhosis. However, the sensitivity and accuracy of these modalities are low for detecting earlier stages of fibrosis and thus are not suitable for staging liver fibrosis over its entire spectrum (14). Over the last several years, new noninvasive methods of assessing liver fibrosis have been developed and investigated, including serum tests, diffusion-weighted MR imaging (DWI), contrast enhanced MR imaging (CE-MRI), ultrasound based transient elastography (UTE) and MR elastography (MRE). Accumulated data showed that the AUROC (area under receiver operating characteristic curve) values are between 77%-91% for serum tests (15-20), 88% for DWI (21), and 83% for CE-MRI (22) to detect the presence of liver fibrosis due to different disease causes. As one of the two existing methods of measuring liver stiffness, UTE has higher AUROC values (0.79-0.98) (23-25), yet it is less accurate for detecting early fibrosis stages and has a high technical failure rate in certain patient subsets (ascites, narrow intercostals space, obesity) (26-28). The other method of measuring liver stiffness, MR elastography (MRE) is the most accurate (AUROC = 92% - 100%) method for detecting and staging liver fibrosis to date, especially in early stages of fibrosis because of its capability of measuring cross-sectional areas of hepatic parenchyma, and the technique is not affected by the ascites and obesity (3, 21, 26, 27, 29-31). In one study, MRE even detected necroinflammation before the onset of fibrosis in patients with NAFLD (32). The detection of early stage fibrosis is of clinical significance as treatments for liver disease are thought to be more effective when compared to later stages of fibrosis. Given its technical advantages and high diagnostic accuracy, this article reviews the application of MR elastography to address clinical questions involving HCV, NAFLD, and methotrexate (MTX) exposure." @default.
- W2433159715 created "2016-06-24" @default.
- W2433159715 creator A5025127141 @default.
- W2433159715 creator A5036548440 @default.
- W2433159715 creator A5080515239 @default.
- W2433159715 creator A5082857859 @default.
- W2433159715 creator A5090743709 @default.
- W2433159715 date "2013-04-01" @default.
- W2433159715 modified "2023-09-24" @default.
- W2433159715 title "MR elastography of liver disease: State of the art" @default.
- W2433159715 cites W1512816181 @default.
- W2433159715 cites W1681077791 @default.
- W2433159715 cites W168896760 @default.
- W2433159715 cites W1964701798 @default.
- W2433159715 cites W1967526953 @default.
- W2433159715 cites W1969562548 @default.
- W2433159715 cites W1969583173 @default.
- W2433159715 cites W1972595485 @default.
- W2433159715 cites W1977036235 @default.
- W2433159715 cites W1985365374 @default.
- W2433159715 cites W1989245785 @default.
- W2433159715 cites W1990430106 @default.
- W2433159715 cites W1993891700 @default.
- W2433159715 cites W2001537101 @default.
- W2433159715 cites W2001837599 @default.
- W2433159715 cites W2002163127 @default.
- W2433159715 cites W2003756626 @default.
- W2433159715 cites W2009135063 @default.
- W2433159715 cites W2009565629 @default.
- W2433159715 cites W2025946383 @default.
- W2433159715 cites W2033182637 @default.
- W2433159715 cites W2035516992 @default.
- W2433159715 cites W2037339586 @default.
- W2433159715 cites W2038774859 @default.
- W2433159715 cites W2040992047 @default.
- W2433159715 cites W2044136233 @default.
- W2433159715 cites W2046500414 @default.
- W2433159715 cites W2047208492 @default.
- W2433159715 cites W2053619386 @default.
- W2433159715 cites W2055280685 @default.
- W2433159715 cites W2057320475 @default.
- W2433159715 cites W2060847352 @default.
- W2433159715 cites W2064421735 @default.
- W2433159715 cites W2065295383 @default.
- W2433159715 cites W2065788317 @default.
- W2433159715 cites W2067162377 @default.
- W2433159715 cites W2067740038 @default.
- W2433159715 cites W2069628571 @default.
- W2433159715 cites W2070783916 @default.
- W2433159715 cites W2072861622 @default.
- W2433159715 cites W2073136205 @default.
- W2433159715 cites W2073213861 @default.
- W2433159715 cites W2074931603 @default.
- W2433159715 cites W2080218879 @default.
- W2433159715 cites W2081006178 @default.
- W2433159715 cites W2083039650 @default.
- W2433159715 cites W2083525176 @default.
- W2433159715 cites W2083950752 @default.
- W2433159715 cites W2084832979 @default.
- W2433159715 cites W2085766690 @default.
- W2433159715 cites W2093566340 @default.
- W2433159715 cites W2097975792 @default.
- W2433159715 cites W2098555833 @default.
- W2433159715 cites W2099318800 @default.
- W2433159715 cites W2099659089 @default.
- W2433159715 cites W2107649622 @default.
- W2433159715 cites W2112496618 @default.
- W2433159715 cites W2113022108 @default.
- W2433159715 cites W2114486042 @default.
- W2433159715 cites W2121353065 @default.
- W2433159715 cites W2131117941 @default.
- W2433159715 cites W2134182464 @default.
- W2433159715 cites W2143712731 @default.
- W2433159715 cites W2146247809 @default.
- W2433159715 cites W2146518439 @default.
- W2433159715 cites W2147506787 @default.
- W2433159715 cites W2149796769 @default.
- W2433159715 cites W2151106782 @default.
- W2433159715 cites W2151253117 @default.
- W2433159715 cites W2158129157 @default.
- W2433159715 cites W2160886890 @default.
- W2433159715 cites W2160964569 @default.
- W2433159715 cites W2169823444 @default.
- W2433159715 cites W2172076494 @default.
- W2433159715 cites W2253667517 @default.
- W2433159715 cites W2318920421 @default.
- W2433159715 cites W2915003917 @default.
- W2433159715 cites W51180389 @default.
- W2433159715 cites W86481016 @default.
- W2433159715 doi "https://doi.org/10.37549/ar1982" @default.
- W2433159715 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4564016" @default.
- W2433159715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26366024" @default.
- W2433159715 hasPublicationYear "2013" @default.
- W2433159715 type Work @default.
- W2433159715 sameAs 2433159715 @default.
- W2433159715 citedByCount "16" @default.
- W2433159715 countsByYear W24331597152013 @default.
- W2433159715 countsByYear W24331597152016 @default.